Ifp Advisors, Inc Phathom Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$9.18 - $11.53 $514 - $645	-56 Reduced 90.32%	6 $1,000
Q3 2022 Nov 08, 2022	BUY	$6.46 - $12.11 $38 - $72	6 Added 10.71%	62 $2,000
Q2 2022 Sep 06, 2022	BUY	$6.2 - $15.5 $347 - $868	56 New	56 $1,000
Q2 2022 Aug 12, 2022	SELL	$6.2 - $15.5 $347 - $868	-56 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$11.55 - $20.06 $646 - $1,123	56 New	56 $0

144

73.6M

42.3K

45.7K

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $292M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.